Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04755439
Other study ID # 2020/KK / 239
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date December 10, 2020
Est. completion date December 10, 2025

Study information

Verified date February 2024
Source Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Deep hypothermic circulatory arrest (DHCA) (18 degree) without cerebral perfusion is a safe technique. Resarchers use this technique in patients with proximal aortic pathologies. During the DHCA period, cerebral silent ischemic events may occur. But the silent ischemic events don't neurological problems with patients.


Description:

It is important to evaluate neurological functions in patients with ascending aortic and aortic root aneurysms who underwent deep hypothermic circulatory arrest (18 degrees) and did not undergo cerebral perfusion. However, neurological changes that are reflected in the clinic are not always encountered. Using preoperative and postoperative diffusion magnetic resonance imaging, silent ischemic lesions that are not reflected in the clinic can be detected. Although there are studies using DW-MRI in patients undergoing different cerebral protection methods in the literature, there are no studies conducted on patients who underwent deep hypothermic circulatory arrest without cerebral perfusion. To detect silent ischemic lesions with preoperative and postoperative diffusion magnetic resonance method in patients with ascending aortic and aortic root aneurysms undergoing deep hypothermic circulatory arrest (18 degrees) and without cerebral perfusion, and to investigate the correlation between preoperative and postoperative neuron-specific enolase levels and serbral findings. Cerebral ischemic lesions that may occur in patients undergoing deep hypothermic circulatory arrest (18 degrees) and undergoing ascending aortic and aortic root aneurysm surgery without cerebral perfusion will be detected, and the clinical follow-up and treatment of the patients will be better managed. We base the imaging of diffusion MR among the examinations to be performed on literature studies that show that withdrawal of patients in the early postoperative period (3rd-7th days) due to the surgical method to be performed without cerebral perfusion under deep hypothermic circulatory arrest, increases the specificity and sensitivity of the test. Therefore, the application of diffusion MR imaging in the early postoperative period (3rd-7th days) after a surgical technique performed under deep hypothermic circulatory arrest (18 degrees) without cerebral perfusion constitutes an indication for diffusion MR in order to detect cerebral ischemic lesions in the early period. Therefore, diffusion MR imaging to be taken in the early period (3rd-7th days) will provide us with the opportunity to create an effective algorithm in terms of patient treatment and follow-up.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 35
Est. completion date December 10, 2025
Est. primary completion date January 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Patients with ascending aorta and aortic root aneurysm. - 18-85 years old Exclusion Criteria: - Patients without ascending aortic and aortic root aneurysms - outside the age range of 18-85, emergency surgery, - Exceeding the magnetic resonance imaging extraction time limit.

Study Design


Intervention

Procedure:
DHCA
DHCA THE USE OF SEREBRAL PROTECTION TECHNIQUE

Locations

Country Name City State
Turkey Dr. Siyami Ersek Thoracic And Cardiovascular Surgery Training And Research Hospital. Istanbul Üsküdar/ Selimiye

Sponsors (1)

Lead Sponsor Collaborator
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measuring postoperative changes in cranial diffusion MR imaging. Changes due to new ischemia or hypoperfusion in the cerebral and cerebellar hemispheres will be measured in terms of volume(cm square or mm square). The measurements will be determined using cranial diffusion mr. Preoperative (1-3 days before operation time) and postoperative (until the 7th day) cranial diffusion MR of the patients will be taken and compared
Secondary the comparison of the preoperative and postoperative neuron spesific enolase enzyms level. The neuron-specific enolase levels of the patients will be checked in the morning of the operation and postoperatively (until 6-36 hours). Neuron-specific enolase enzyme levels will be measured from the blood sample. The neuron-specific enolase levels of the patients will be checked in the morning of the operation and postoperatively (up to 6-36 hours).
See also
  Status Clinical Trial Phase
Completed NCT03095742 - Bedside Monitoring of Cerebral Energy State During the Peri-cardiac Arrest Period N/A
Not yet recruiting NCT05947617 - Safety, Efficacy, and Dosing of VIX001 in Patients With Neurological Symptoms of Post Acute COVID-19 Syndrome (PACS). Phase 1
Enrolling by invitation NCT06360666 - Clinical Outcomes in Adult Patients Undergoing Laparoscopic Surgery Under Neuraxial Anesthesia
Not yet recruiting NCT05363098 - The Cerebral-Respiratory Interaction During Spontaneous Breathing Ventilation in Neurosurgical Patients (CeRes-SB)
Completed NCT03399890 - The Influence of Neuromuscular Reversal on Neurological Physical Exam Time in Lumbar Neurosurgical Cases. N/A
Recruiting NCT05843214 - Transcranial Doppler, Optic Nerve Envelope Diameter and Quantitative Pupillometry Measurements
Completed NCT04363749 - COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities N/A
Completed NCT05097066 - Patterns and Outcomes of Neurosurgery in England Over a Five-year Period